PA
IDXX icon

Pineridge Advisors’s Idexx Laboratories IDXX Stock Holding History

Pineridge Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12
Closed -$6.44K – 512
2025
Q2 		$6.44K Hold
12
– – ﹤0.01% 271
2025
Q1 		$5.04K Buy
+12
New +$5.21K ﹤0.01% 308
2024
Q1 		– Sell
-107
Closed -$59.4K – 718
2023
Q4 		$59.4K Buy
+107
New +$50.2K 0.02% 151

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Pineridge Advisors's IDXX Position: Q3 2025 in Review

Pineridge Advisors sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 12 shares — an estimated $6.44K sold.

Pineridge Advisors first reported a position in IDXX in Q4 2023 and held it in 3 quarters. The position peaked at $59.4K in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Pineridge Advisors reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Pineridge Advisors sold 12 Idexx Laboratories shares in Q3 2025, an estimated $6.44K.
  • Pineridge Advisors first reported a position in Idexx Laboratories in Q4 2023 and held it in 3 quarters.
  • Pineridge Advisors's Idexx Laboratories position peaked at $59.4K in Q4 2023.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.